'David v Goliath' Orexo ruling hugely significant for Orexo as it continues to meet the opioid treatment challenge
Stephen McNeeney, partner and pharmaceuticals expert, comments on the news that Orexo AB has won its patent appeal with Teva over its Zubsolv opioid addiction drug.